This is a news story, published by Texas A&M Today, that relates primarily to Texas A&M University College of Medicine news.
For more biology news, you can click here:
more biology newsFor more news from Texas A&M Today, you can click here:
more news from Texas A&M TodayOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about
Nasal Spray. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Extracellular Vesicles news, microglia news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
AlzheimerTexas A&M Today
•
77% Informative
A new therapy may delay Alzheimer’s disease progression by years .
Researchers at Texas A&M University College of Medicine used nasal spray to target cells perpetuating chronic neuroinflammation.
Researchers found decreased inflammation in the brain and a reduction in the build-up of plaques and proteins thought to be linked to the progressive loss of neurons.
VR Score
78
Informative language
83
Neutral language
35
Article tone
formal
Language
English
Language complexity
84
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
detected
Known propaganda techniques
not detected
Time-value
long-living
External references
4
Source diversity
3
Affiliate links
no affiliate links